Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
This post contains full spoilers for Ms. Marvel and other MCU properties. If you're not caught up yet, check out our spoiler-free Ms. Marvel finale review. Ms. Marvel's debut season appeared to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results